Home
Journal Issues
Current Issue
In Press
Archive
Guidelines
About the journal
Author Guidelines
Peer-Review Policy
Open Access and Copyright
Author Agreement Form
Create Account
Login
Please don't use dangerous characters
Title
Abstract
Full Text
Keywords
Author
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2025, Vol 14, No. 4
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Case Report
1. A curious case of persistently relapsing hyperkalemia in an ESRD patient on maintenance hemodialysis following bioprosthetic aortic valve replacement – a potential case for the use of the new agent, patiromer, for hyperkalemia management
Macaulay Amechi Chukwukadibia Onuigbo*, Nneoma Agbasi, Fidelis Oguejiofor, Charles Odenigbo
J Renal Inj Prev
. 2017;6(1): 30-34.
doi:
10.15171/jrip.2017.06
PMCID:
PMC5414516
PMID:
28487869
Scopus ID:
85040679565
Article
PDF
XML
Cited By:
0
0
0
×
A curious case of persistently relapsing hyperkalemia in an ESRD patient on maintenance hemodialysis following bioprosthetic aortic valve replacement – a potential case for the use of the new agent, patiromer, for hyperkalemia management
Mini-Review
2. Benefits and risks of dual inhibition of the renin– angiotensin aldosterone system for kidney disease
Nader Nourimajalan*
, Ahmad Shajari
, Sarasadat Moghadasimousavi
J Renal Inj Prev
. 2022;11(2): e31969.
doi:
10.34172/jrip.2022.31969
Scopus ID:
85130368722
Article
PDF
XML
Cited By:
0
0
×
Benefits and risks of dual inhibition of the renin– angiotensin aldosterone system for kidney disease
